Cornercap Investment Counsel’s Q32 Bio QTTB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-2,104
Closed -$33.5K 667
2023
Q2
$33.5K Sell
2,104
-2,403
-53% -$43.1K 0.01% 548
2023
Q1
$83.6K Hold
4,507
0.01% 539
2022
Q4
$102K Buy
4,507
+66
+1% +$1.75K 0.02% 537
2022
Q3
$129K Hold
4,441
0.02% 518
2022
Q2
$157K Buy
+4,441
New +$152K 0.03% 500

Other funds holding QTTB

Cornercap Investment Counsel's QTTB Position: Q3 2023 in Review

Cornercap Investment Counsel sold out of Q32 Bio (QTTB) in Q3 2023, closing a stake of 2,104 shares — an estimated $33.5K sold.

Cornercap Investment Counsel first reported a position in QTTB in Q2 2022 and held it in 5 quarters. The position peaked at $157K in Q2 2022. 58 funds tracked by Wall St. Rank hold QTTB as of Q3 2023.

  • Cornercap Investment Counsel reported no remaining Q32 Bio position as of Q3 2023 after selling out during the quarter.
  • Cornercap Investment Counsel sold 2,104 Q32 Bio shares in Q3 2023, an estimated $33.5K.
  • Cornercap Investment Counsel first reported a position in Q32 Bio in Q2 2022 and held it in 5 quarters.
  • Cornercap Investment Counsel's Q32 Bio position peaked at $157K in Q2 2022.
  • 58 funds tracked by Wall St. Rank held Q32 Bio as of Q3 2023.

Based on Cornercap Investment Counsel's 13F filing for Q3 2023, filed 13 Nov 2023.